Breast Cancer

domain

Cancers originating in the breast.

103

Centers

9,609

Active Trials

328

NIH Grants

$25.9B

NCI Funding

General Cancer Types(216)

NameCenters
Invasive Breast Carcinoma87
Anatomic Stage I Breast Cancer AJCC v885
Anatomic Stage II Breast Cancer AJCC v885
Anatomic Stage III Breast Cancer AJCC v885
Breast Carcinoma83
Triple-Negative Breast Carcinoma83
Breast Adenocarcinoma82
Anatomic Stage IV Breast Cancer AJCC v881
Breast Ductal Carcinoma In Situ81
Metastatic Breast Carcinoma81
HER2 Positive Breast Carcinoma79
Stage III Breast Cancer AJCC v777
Prognostic Stage II Breast Cancer AJCC v876
HER2 Negative Breast Carcinoma73
Hormone Receptor Positive Breast Carcinoma73
Prognostic Stage III Breast Cancer AJCC v873
Prognostic Stage I Breast Cancer AJCC v872
Anatomic Stage 0 Breast Cancer AJCC v865
Locally Advanced Breast Carcinoma52
Early Stage Breast Carcinoma49
Metastatic Breast Adenocarcinoma48
Recurrent Breast Adenocarcinoma47
Breast Cancer Survivor41
Breast Neoplasm38
Stage III Breast Cancer AJCC v634
Breast Cancer Screening31
Resistant Breast Cancer19
Hormone Receptor Negative Breast Carcinoma17
Bilateral Breast Carcinoma14
Metastatic Breast Cancer (MBC)12
Breast Lobular Carcinoma In Situ11
Breast Cancer Prevention10
Breast Cancer Metastases9
Breast Disease9
Breast Cancer Survivorship7
Incident Breast Cancer6
Locally Advanced Triple-Negative Breast Carcinoma6
Breast Atypical Hyperplasia5
Breast Surgery5
Advanced or Metastatic Breast Cancer4
Benign Breast Neoplasm4
Breast Cancer Surgery4
Breast Cancer Triple Negative4
High Risk for Breast Cancer4
Breast Cancer Radiation3
HER2 Positive Breast3
Inflammatory Breast Carcinoma3
Mucinous Ductal Breast Carcinoma3
Non-Metastatic Breast Cancer3
Papillary Ductal Breast Carcinoma3
PIK3CA Mutant Metastatic Breast Cancer3
Recurrent Triple-Negative Breast Carcinoma3
Tubular Ductal Breast Carcinoma3
Adenocarcinoma of the Breast2
Anatomic Stage I Breast Cancer2
Anatomic Stage II Breast Cancer2
Anatomic Stage III Breast Cancer2
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome2
Breast Cancer (HR+HER2-)2
Breast Cancer Lymphedema2
Breast Cancer, Breast Neoplasms2
Breast Neoplasm Malignant Female2
Breast Reconstruction After Mastectomy2
Carcinoma, Metastatic Breast2
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma2
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma2
Ductal Breast Cancer2
Estrogen-receptor-low Breast Cancer2
Excluding Breast Cancer2
HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma2
HER2 Low Breast Adenocarcinoma2
HER2-Positive Early Stage Breast Cancer2
High Risk Breast Carcinoma2
Hormone Receptor Positive Breast Adenocarcinoma2
HR+ Metastatic Breast Cancer2
Human Epidermal Growth Factor 2 Low Breast Cancer2
Indolent Metastatic Breast Cancer2
Inflammatory Breast Cancer Stage III2
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer2
Invasive Breast Lobular Carcinoma2
Left Sided Breast Cancer2
Locally Advanced Unresectable HER2-Negative Breast Carcinoma2
Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma2
Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer2
Malignant Breast Neoplasm2
Mastectomy and Breast Reconstruction2
Metaplastic Breast Carcinoma2
Metastatic Breast Cancer ( HER2 Negative)2
Metastatic Breast Cancer in the Liver2
Node-positive Breast Cancer2
Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer2
Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Cancer2
Refractory Triple-Negative Breast Carcinoma2
Stage 0 Breast Carcinoma2
Stage 0-III Breast Cancer2
Stage II Breast Carcinoma2
Stage IV (Metastatic) Breast Cancer2
Tumors, Breast2
Adjuvant Radiotherapy for Breast Cancer1
Advanced HER2-positive Breast Cancer1
Advanced or Metastatic ER+ Breast Cancer1
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v81
Axilla; Breast1
Bone Metastases From Breast or Prostate Cancer1
Brain Metastases From Breast Cancer1
Breast - Female1
Breast - Male1
Breast Benign1
Breast Cancer Invasive Nos1
Breast Cancer Metastatic Breast Cancer1
Breast Cancer Stage IIB1
Breast Cancer Stage IIIA1
Breast Cancer Surgery Pain1
Breast Cancer With Chronic Lymphedema1
Breast Cancer(BC) Survivors1
Breast Carcinoma Metastatic in the Brain1
Breast Ductal Carcinoma1
Breast Fibroadenoma1
Breast Lymphedema1
Breast Pain1
Breast Reconstruction With Silicone Implants1
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients1
Cutaneous Breast Cancer1
Ductal Carcinoma in Situ of the Breast1
ER+ and AR+ Breast Cancer1
ERany/PRany/HER2+ Breast Cancer1
Estrogen Receptor Breast Cancer1
Estrogen Receptor Positive and HER2 Negative Breast Cancer1
Estrogen-receptor Positive Invasive Metastatic Breast Cancer1
HER-2 Positive Malignant Carcinoma of Breast1
HER2 Negative Breast Adenocarcinoma1
HER2 Positive Metastatic Breast Cancers1
HER2-Positive Breast Cancer Survivors1
HER2-Positive Early Breast Cancer1
HER2/Neu-positive Breast Cancer1
High Risk for Developing Breast Cancer1
Hormone Receptor (HR)-Positive Breast Cancer1
Hormone Receptor Negative Malignant Tumor Breast Triple1
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer1
Hormone Receptor Positive Metastatic Breast Cancer1
Hormone-sensitive Metastatic Breast Cancer1
HR+/HER2- Ductal and Lobular Breast Cancer1
Human Epithelial Receptor (HER)-2 Positive Breast Cancer1
In Situ Breast Cancer1
Inflammatory Breast Cancer Stage IV1
Invasive Adenocarcinoma of the Breast1
Invasive Breast Cancer (Stage I-III)1
Invasive Ductal Breast Carcinoma Stage IV1
Invasive Ductal Carcinoma, Breast1
Lobular Breast Carcinoma Stage IV1
Localized Estrogen Receptor-Positive Breast Carcinoma1
Localized Human Epidermal Growth Factor Receptor (HER2)-Negative Breast Carcinoma1
Locally Advanced HER2-Positive Breast Carcinoma1
Locally Recurrent/Metastatic Triple Negative Breast Cancer1
Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Cancer1
Lymphedema, Breast Cancer1
Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M)1
Malignant Neoplasm of Female Breast1
Metastatic Breast Cancer to the Brain1
Metastatic Breast Lobular Carcinoma1
Metastatic ER+ Breast Cancer1
Metastatic HER2-negative Breast1
Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer1
Metastatic Invasive Breast Cancer1
Metastatic Lobular Breast Carcinoma1
Metastatic or Locally-advanced Unresectable Breast Cancer1
Non-Metastatic Breast Carcinoma1
Non-metastatic Invasive Breast Cancer1
Oligometastatic Breast Carcinoma1
Osseous Lesions From Metastatic Breast Cancer1
Paget Disease of the Breast With Intraductal Carcinoma1
Paget Disease of the Breast With Invasive Ductal Carcinoma1
PALB2-Mutated Breast Carcinoma1
Patients With Lung, Breast, Head and Neck, or Pelvic Malignancies1
Phyllodes Breast Tumor1
Post-menopausal ER+ Stage I-IIIA Primary Operable Breast Cancer1
Primary Hormone Receptor Positive Breast Cancer1
Progressive Breast Cancer1
Radiation Therapy for Primary Breast Cancer1
Recurrent or Metastatic Breast Cancer1
Stage 4 Breast Cancer1
Stage I Breast Carcinoma1
Stage I, II and III A Breast Cancer1
Stage IA-IIA Breast Cancer1
Stage IIb Breast Cancer (T3N0)1
Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4)1
Stage III Breast Carcinoma1
Suspicion of, or Known Breast Cancer1
TN ER-/PR-/HER2- Breast Cancer1
Triple Negative Breast Cancer Malignancies1
Triple Negative Breast, Prostate, Colorectal, Gastric, Ovarian, Pancreatic, Esophageal, Soft Tissue Sarcoma, and Head & Neck Cancer1
Unresectable Locally Advanced Invasive Breast Cancer1
Women at Increased Risk for Developing Breast Carcinoma1
Women With Stage I or II Breast Cancer Undergoing Active Radiation Therapy1
Women With Suspected or Confirmed Recurrent Breast Cancer1
Advanced Breast Adenocarcinoma—
Advanced Hormone Receptor-Positive Breast Carcinoma—
BRCA Hereditary Breast Carcinoma—
Breast Angiosarcoma—
Breast Cancer by AJCC v6 Stage—
Breast Cancer by AJCC v7 Stage—
Breast Cancer by AJCC v8 Anatomic Stage—
Breast Cancer by AJCC v8 Prognostic Stage—
Breast Cancer Therapeutic Procedure—
Breast Carcinoma by Gene Expression Profile—
Breast Disorder—
Breast Lobular Carcinoma—
Breast Neuroendocrine Neoplasm—
Hereditary Breast Carcinoma—
Invasive Breast Carcinoma of No Special Type—
Locally Advanced Breast Adenocarcinoma—
Locally Advanced Hormone Receptor-Positive Breast Carcinoma—
Locally Recurrent Breast Carcinoma—
Metastatic Breast Carcinoma in the Central Nervous System—
NCI CTEP SDC Breast Neoplasm Category Terminology—
Reproductive System and Breast Disorders, CTCAE 5.0—

Top Centers for Breast Cancer(103)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
High-Volume Research Center
72.8
2
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
High-Volume Research Center
72.3
3
Boston University Cancer CenterBoston, MA
High-Volume Research Center
71.9
4
University of Illinois Cancer CenterChicago, IL
High-Volume Research Center
71.4
5
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
High-Volume Research Center
70.9
6
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
High-Volume Research Center
70.3
7
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
High-Volume Research Center
70.3
8
Cancer Center at IllinoisUrbana, IL
Active Research Program
69.6
9
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
69.1
10
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
Active Research Program
68.6
11
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
67.7
12
Cleveland Clinic Cancer CenterCleveland, OH
Active Research Program
67.7
13
Princess Margaret Cancer CentreToronto, ON
Active Research Program
67.7
14
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
66.8
15
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
Active Research Program
66.1
16
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
66.1
17
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
64.5
18
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
64.5
19
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
64.5
20
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
64.5
21
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
Active Research Program
64.5
22
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
Active Research Program
63.1
23
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
62.7
24
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
62.2
25
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
61.3
26
Tampa General Hospital Cancer InstituteTampa, FL
Active Research Program
61.3
27
BC CancerVancouver, BC
Active Research Program
61.3
28
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
Active Research Program
59.9
29
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
Active Research Program
59.9
30
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
Active Research Program
59.9
31
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
Active Research Program
59.0
32
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
58.5
33
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
57.9
34
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
57.9
35
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
56.9
36
Louisiana Cancer Research CenterNew Orleans, LA
Active Research Program
56.9
37
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
Active Research Program
55.1
38
Stony Brook Cancer CenterStony Brook, NY
Active Research Program
55.1
39
Penn State Cancer InstituteHershey, PA
Active Research Program
55.1
40
University of Texas Medical Branch Cancer CenterGalveston, TX
Active Research Program
55.1
41
Medical College of Wisconsin Cancer CenterMilwaukee, WI
Active Research Program
55.1
42
Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA
NCI Comprehensive
Active Research Program
55.1
43
The University of Vermont Cancer CenterBurlington, VT
Active Research Program
53.0
44
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
Active Research Program
53.0
45
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
53.0
46
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN
NCI Comprehensive
Active Research Program
51.2
47
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
Active Research Program
51.2
48
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD
NCI Comprehensive
Active Research Program
51.2
49
UPMC Hillman Cancer CenterPittsburgh, PA
NCI Comprehensive
Active Research Program
51.2
50
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
Active Research Program
51.2
51
Georgia Cancer Center, Augusta UniversityAugusta, GA
Active Research Program
49.6
52
University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR
Active Research Program
49.6
53
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
Active Research Program
48.2
54
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
48.2
55
University of Hawai‘i Cancer CenterHonolulu, HI
NCI Clinical
Active Research Program
48.2
56
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
48.2
57
Wilmot Cancer Institute, UR MedicineRochester, NY
NCI Clinical
Active Research Program
45.5
58
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
Active Research Program
45.5
59
Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA
NCI Comprehensive
Active Research Program
45.5
60
UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC
NCI Comprehensive
Active Research Program
45.5
61
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
45.5
62
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
45.5
63
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
45.5
64
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
Active Research Program
45.5
65
UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
Active Research Program
42.9
66
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
Active Research Program
42.9
67
Upstate Cancer CenterSyracuse, NY
Active Research Program
42.9
68
Northwell Health Cancer InstituteNew York, NY
Active Research Program
41.6
69
UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA
NCI Comprehensive
Active Research Program
41.6
70
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
41.6
71
Legorreta Cancer Center at Brown UniversityProvidence, RI
Active Research Program
39.5
72
Montefiore Einstein Comprehensive Cancer CenterBronx, NY
NCI Comprehensive
Active Research Program
39.5
73
Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX
NCI Comprehensive
Active Research Program
39.5
74
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
39.5
75
UF Health Cancer InstituteGainesville, FL
NCI Clinical
Active Research Program
39.5
76
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
Active Research Program
39.5
77
Georgetown Lombardi Comprehensive Cancer CenterWashington, DC
NCI Comprehensive
Active Research Program
37.4
78
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
Active Research Program
37.4
79
Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC
NCI Comprehensive
Active Research Program
37.4
80
University of Michigan Rogel Cancer CenterAnn Arbor, MI
NCI Comprehensive
Active Research Program
36.0
81
OHSU Knight Cancer InstitutePortland, OR
NCI Comprehensive
Active Research Program
36.0
82
Loma Linda University Cancer CenterLoma Linda, CA
Active Research Program
36.0
83
The Jackson Laboratory Cancer CenterBar Harbor, ME
NCI Basic_laboratory
Contributing Research Center
33.5
84
Ellis Fischel Cancer Center, MU Health CareColumbia, MO
Contributing Research Center
33.5
85
Mays Cancer Center at UT Health San Antonio MD AndersonSan Antonio, TX
NCI Clinical
Contributing Research Center
33.5
86
Murtha Cancer Center at Walter Reed BethesdaBethesda, MD
Contributing Research Center
33.5
87
Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChicago, IL
NCI Comprehensive
Contributing Research Center
33.5
88
UCI Chao Family Comprehensive Cancer CenterOrange, CA
NCI Comprehensive
Contributing Research Center
33.5
89
UK Markey Cancer CenterLexington, KY
NCI Comprehensive
Contributing Research Center
33.5
90
UofL James Graham Brown Cancer CenterLouisville, KY
Contributing Research Center
33.5
91
Mount Sinai Tisch Cancer CenterNew York, NY
NCI Comprehensive
Contributing Research Center
30.3
92
Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN
NCI Comprehensive
Contributing Research Center
30.3
93
Hollings Cancer CenterCharleston, SC
NCI Clinical
Contributing Research Center
30.3
94
Livestrong Cancer InstitutesAustin, TX
Contributing Research Center
30.3
95
WVU Cancer InstituteMorgantown, WV
Contributing Research Center
30.3
96
Cardinal Bernardin Cancer CenterMaywood, IL
Contributing Research Center
30.3
97
UMass Memorial Health Cancer CenterWorcester, MA
28.5
98
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer CenterBaltimore, MD
NCI Comprehensive
28.5
99
Sandra and Edward Meyer Cancer Center at Weill Cornell MedicineNew York, NY
—
100
O’Neal Comprehensive Cancer Center at the University of Alabama at BirminghamBirmingham, AL
NCI Comprehensive
—
101
GW Cancer CenterWashington, DC
—
102
Sanford Burnham Prebys Medical Discovery InstituteLa Jolla, CA
NCI Basic_laboratory
—
103
UMMC Cancer Center and Research InstituteJackson, MS
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →